Eli Lilly is a leader in the weight management market, with only a single worthy challenger. The pharmaceutical giant has a ...

Novo Nordisk’s semaglutide and Eli Lilly’s tirzepatide — are now available in the Indian market. Here’s how they work, how ...

An innovative weight-loss medication called SANA has shown promising results in early trials, offering hope in the fight ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...

Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...

Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

In the race to make the most tolerable obesity drug, there seems to be no clear winner—at least not according to analysts ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

GLP-1 agonists like Wegovy, Ozempic, and Mounjaro might benefit heart and brain health—but research suggests they might also ...

They may have benefits, but whether they’re necessary is up for debate. We unpack the research and consult health experts about whether sugar substitutes deserve a spot in your weight loss diet.

A separate Prime analysis, however, of year-over-year claims data for Wegovy and Zepbound only found an improvement in ...